Investigating the Effects of the Digital App Rheumabuddy4.1 in a Clinical Set-up in Patients With Rheumatoid Arthritis - Trial NCT06337786

Timeline & Enrollment

Primary Outcome

Primary Outcome

Summary

Rheumatoid arthritis (RA) is one of the most frequently occurring autoimmune rheumatic
 diseases, affecting an estimated 1% of the global population (1). RA is a chronic
 inflammatory disease that leads to the development of synovial inflammation and effusion,
 ultimately followed by joint destruction and permanent disability.
 
 There is a discrepancy in the understanding of what's of importance when living a life with a
 chronic disease.
 
 The importance of patients' perspectives concerning disease- and treatment related impacts,
 is of crucial importance when involving patients in decisions about treatment, and to support
 the patients in optimal medication-taking behaviour to ensure patient health and reduce
 health care costs. There are still unmet needs that have a huge impact on quality of life
 (QoL) such as fatigue, pain, sleep and psychological issues, etc, which need to be taken
 seriously as these can have severe and debilitating consequences for the individual.
 
 The aim of this study is to investigate and evaluate the effects of the digital app
 RheumaBuddy4.1 (RB4.1) and the ability to provide support and increase quality of life in
 patients with RA

ICD-10 Classifications